Overview
Study Evaluating Multiple Oral Doses of PPM-204 in Healthy Japanese Male Subjects
Status:
Completed
Completed
Trial end date:
2007-03-01
2007-03-01
Target enrollment:
0
0
Participant gender:
Male
Male
Summary
A study evaluating the safety and pharmacokinetics of multiple oral doses of an investigational oral diabetic agent when given to healthy Japanese male volunteers.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Criteria
Inclusion Criteria:- Men, aged 20 to 45 years, inclusive
- Body mass index in the range of 17.6 to 26.4 kg/m2
- Healthy as determined by the investigator on the basis of medical history, physical
examination, clinical laboratory test results, vital signs, and 12-lead
electrocardiogram (ECG)
Exclusion Criteria:
- History of cardiac, thyroid, muscle, and kidney abnormalities
- History of NSAID induced bronchospasm or asthma
- History of any clinically important allergies